4.7 Article

Synergistic Combinations of Multiple Chemotherapeutic Agents in High Capacity Poly(2-oxazoline) Micelles

Journal

MOLECULAR PHARMACEUTICS
Volume 9, Issue 8, Pages 2302-2313

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/mp300159u

Keywords

block copolymer; combination therapy; drug delivery; drug formulation; nanomedicine; polymeric micelles; synergistic cytotoxicity

Funding

  1. National Cancer Institute Alliance for Nanotechnology in Cancer [U01 CA116591]
  2. China Scholarship Council (CSC)
  3. PCSIRT
  4. National Institutes of Health [RR021937]

Ask authors/readers for more resources

Many effective drugs for cancer treatment are poorly water-soluble. In combination chemotherapy, needed excipients in additive formulations are often toxic and restrict their applications in clinical intervention. Here, we report on amphiphilic poly(2-oxazoline)s (POx) micelles as a promising high capacity delivery platform for multidnig cancer chemotherapy. A variety of binary and ternary drugs combinations of paclitaxel (PTX), docetaxel (DTX), 17-allylamino-17-demethoxygeldanamycin (17-AAG), etoposide (ETO) and bortezomib (BTZ) were solubilized in defined polymeric micelles achieving unprecedented high total loading capacities of up to 50 wt % drug per final formulation. Multidrug loaded POx micelles showed enhanced stability in comparison to single-drug loaded micelles. Drug ratio dependent synergistic cytotoxicity of micellar ETO/17-AAG was observed in MCF-7 cancer cells and of micellar BTZ/17-AAG in MCF-7, PC3, MDA-MB-231 and HepG2 cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available